Bliss GVS Pharma Ltd (BLISSGVS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 730684, "name": "Bliss GVS Pharma", "stock_name": "Bliss GVS Pharma", "full_name": "Bliss GVS Pharma Ltd", "name_url": "stocks-analysis/bliss-gvs-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "661.55", "chg": -20.3, "chgp": "-2.98%", "dir": -1, "prev_price": "681.85", "mcapval": "7,195.00 Cr", "mcap": "Small Cap", "scripcode": 506197, "symbol": "BLISSGVS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE416D01022", "curr_date": "Sep 21, 03:30 PM", "curr_time": "19:57 PM", "last_traded_at": "Sep 21, 03:30 PM IST", "bse_nse_vol": "1.95 lacs", "exc_status": "Active", "traded_date": "Sep 21, 2026", "traded_date_str": "2026 09 21", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Bliss GVS Pharma Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-buy-4199651", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BlissGVSPharmaL_mojoScore_4199651.png", "date": "2026-09-21 10:11:31", "description": "Bliss GVS Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Below All Moving Averages and Now at Lower Circuit: Bliss GVS Pharma Ltd Loses 5.0% in a Single Session", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4194975", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BlissGVSPharmaL_stocks_hitting_lower_circuit_4194975.png", "date": "2026-09-16 10:00:34", "description": "At Rs 650.75, sellers were still queuing — but there were no buyers willing to take the other side. Bliss GVS Pharma Ltd locked at its lower circuit of 5.0% on 16 Sep 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a thinly traded small-cap stock." }, { "title": "Bliss GVS Pharma Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4193547", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BlissGVSPharmaL_stocks_hitting_lower_circuit_4193547.png", "date": "2026-09-15 11:00:14", "description": "At Rs 695, sellers were still queuing — but there were no buyers willing to take the other side. Bliss GVS Pharma Ltd locked at its lower circuit of 5% on 15 Sep 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a small-cap stock." }, { "title": "Bliss GVS Pharma Gains 8.04%: 5 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-804-5-key-factors-driving-the-weeks-rally-4191449", "imagepath": "", "date": "2026-09-12 14:04:34", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>7 Sep:</strong> New 52-week and all-time high of Rs.702.10; upper circuit hit amid strong buying pressure</p>\n <p><strong>8 Sep:</strong> Stock hits new 52-week and all-time high of Rs.720, continuing upward momentum</p>\n <p><strong>9 Sep:</strong> New 52-week and all-time high of Rs.733.75 reached, followed by profit-taking</p>\n <p><strong>10 Sep:</strong> Price recovers with a 1.59% gain amid high volume</p>\n <p><strong>11 Sep:</strong> Week closes at Rs.722.45, up 2.66% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"s..." }, { "title": "Bliss GVS Pharma Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-buy-4189120", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BlissGVSPharmaL_mojoScore_4189120.png", "date": "2026-09-10 10:11:12", "description": "Bliss GVS Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 733.75", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-of-rs73375-4187643", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BlissGVSPharmaL_priceRelatedfactors_4187643.png", "date": "2026-09-09 09:55:44", "description": "From a low of Rs 118.35 to a new peak of Rs 733.75, Bliss GVS Pharma Ltd has surged an extraordinary 355.61% over the past year, defying the broader market’s downward trend. This remarkable ascent culminated in a fresh 52-week high on 9 Sep 2026, driven predominantly by a confluence of bullish technical indicators and sustained price momentum." }, { "title": "Bliss GVS Pharma Ltd Hits All-Time High of Rs 733.75 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-at-rs73375-on-09-sep-2026-4187539", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BlissGVSPharmaL_priceRelatedfactors_4187539.png", "date": "2026-09-09 09:32:45", "description": "" }, { "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 720", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-of-rs720-amid-strong-momentum-4186243", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BlissGVSPharmaL_priceRelatedfactors_4186243.png", "date": "2026-09-08 09:58:12", "description": "From a 52-week low of Rs 118.35 to a new peak of Rs 720, Bliss GVS Pharma Ltd has surged an extraordinary 354.49% in the past year, defying the broader market’s downward trend. This remarkable rally is underpinned by a confluence of strong technical indicators and sustained price momentum that have propelled the stock to fresh highs despite a weakening Sensex." }, { "title": "Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Reaches All-Time High", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-all-time-high-of-rs720-on-8-september-2026-4186092", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BlissGVSPharmaL_priceRelatedfactors_4186092.png", "date": "2026-09-08 09:31:30", "description": "" } ], "total": 444, "sid": "730684", "stock_news_url": "https://www.marketsmojo.com/news/bliss-gvs-pharma-730684" }, "announcements": [ { "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the second quarter and half year ended September 30, 2019 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshkati a Regional Daily, on November 13, 2019.", "source": "NSE", "caption": "Bliss GVS Pharma Limited - Updates", "datetime": "13-Nov-2019" }, { "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Monday, November 11, 2019 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019 published in The Economic Times an English Daily and Maharashtra Times a Regional Daily, on November 05, 2019.", "source": "NSE", "caption": "Bliss GVS Pharma Limited - Updates", "datetime": "05-Nov-2019" }, { "details": "Bliss GVS Pharma Limited has informed the Exchange regarding a press release dated October 07, 2019, titled \"we enclose herewith Press Release announcing that Kremoint Pharma Private Limited, India, a 70% subsidiary of Bliss GVS Pharma Limited (BGPL) has received a compliant certification from the U.S. Food and Drug Administration (FDA) that was based on the inspection conducted at the Company s facility located at M.I.D.C, Ambernath (East), Thane-District.\".", "source": "NSE", "caption": "Bliss GVS Pharma Limited - Press Release", "datetime": "09-Oct-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Bliss GVS Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Jul 26", "dt": "2026-07-08", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08", "dt": "2008-03-11", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08", "dt": "2008-09-26", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

7 Sep: New 52-week and all-time high of Rs.702.10; upper circuit hit amid strong buying pressure

8 Sep: Stock hits new 52-week and all-time high of Rs.720, continuing upward momentum

9 Sep: New 52-week and all-time high of Rs.733.75 reached, followed by profit-taking

10 Sep: Price recovers with a 1.59% gain amid high volume

11 Sep: Week closes at Rs.722.45, up 2.66% on the day

Read full news article

Bliss GVS Pharma Ltd is Rated Buy

2026-09-10 10:11:12

Bliss GVS Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 733.75

2026-09-09 09:55:44

From a low of Rs 118.35 to a new peak of Rs 733.75, Bliss GVS Pharma Ltd has surged an extraordinary 355.61% over the past year, defying the broader market’s downward trend. This remarkable ascent culminated in a fresh 52-week high on 9 Sep 2026, driven predominantly by a confluence of bullish technical indicators and sustained price momentum.

Read full news article

Bliss GVS Pharma Ltd Hits All-Time High of Rs 733.75 as Momentum Builds Across Timeframes

2026-09-09 09:32:45

Read full news article

Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 720

2026-09-08 09:58:12

From a 52-week low of Rs 118.35 to a new peak of Rs 720, Bliss GVS Pharma Ltd has surged an extraordinary 354.49% in the past year, defying the broader market’s downward trend. This remarkable rally is underpinned by a confluence of strong technical indicators and sustained price momentum that have propelled the stock to fresh highs despite a weakening Sensex.

Read full news article

Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Reaches All-Time High

2026-09-08 09:31:30

Read full news article